arrow
L

Luca Bianchi

University of Rome Tor Vergata
H指数:49
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cemiplimab in cutaneous squamous cell carcinoma: a longer follow-up study focusing on the late toxicities

西米普利单抗在皮肤鳞状细胞癌中的应用:一项关注晚期毒性的长期随访研究

2026-09-060
PRE
Baricitinib versus ritlecitinib for severe alopecia areata: A 24-week real-world study
2026-09-010
PRE
Baricitinib for adult atopic dermatitis: real-world effectiveness, safety, and response predictors

巴瑞替尼治疗成人特应性皮炎:真实世界疗效、安全性及应答预测因子

2025-11-030
OAAI
Peripheral blood inflammation indexes correlate with advanced stages in cutaneous melanoma: a single-center retrospective study

外周血炎症指标与皮肤黑色素瘤晚期相关:一项单中心回顾性研究

2025-10-011
PRE
Efficacy and Safety of Glycopyrronium Bromide 1% Cream in Axillary and Extra-Axillary Primary Hyperhidrosis: A Real-Life Two-Center Experience on 68 Subjects

格鲁匹罗尼溴化物1%乳膏在腋窝和非腋窝原发性多汗症中的疗效与安全性:一项基于68例患者的真实世界双中心经验研究

2025-08-290
OAAI
Effectiveness and Safety of Adalimumab Biosimilars in Pediatric Psoriasis: A Multi-Center International Experience

阿达木单抗生物类似药在儿童银屑病中的有效性与安全性:一项多中心国际经验

2025-06-280
OA
BRodalumab effectiveness in psoriatic patients that experienced anti-IL17 Intra-Class failure: a multicentre, retrospective study (BRIC - Study) IL-PSO (Italian Landscape Psoriasis)

BRodalumab在经历抗IL-17类药物无效的银屑病患者中的疗效:一项多中心回顾性研究(BRIC研究)IL-PSO(意大利银屑病全景研究)

2025-05-010
PRE
A long-term real-world safety study of guselkumab in patients with psoriasis who have infectious comorbidities, malignancies or heart disease: the EARLY study

古塞库单抗在患有感染性合并症、恶性肿瘤或心脏病的银屑病患者中的长期真实世界安全性研究:EARLY研究

2025-04-160
PRE
Evaluating the Efficacy of Bimekizumab across the Different Sensitive Areas in Moderate-to-Severe Psoriasis: A 52-week Italian Multicenter Real-Life Lazio Experience

评估Bimekizumab在不同敏感区域治疗中重度银屑病的疗效:一项为期52周的意大利多中心真实世界拉齐奥经验

2025-04-110
OA
Enhancing Skin Cancer Prevention and Awareness in the Italian Population: Insights from the Save Your Skin Screening Campaign

提升意大利人群皮肤癌预防与意识:来自“拯救你的皮肤”筛查运动的经验与启示

2025-04-110
PRE
The nature of the post-translational modifications of the autoantigen LL37 influences the autoreactive T-helper cell phenotype in psoriasis

LL37自身抗原的翻译后修饰的性质影响银屑病中自身反应性Th细胞的表型

2025-04-090
OA
Predictive Factors for Super Responder Status and Long-Term Effectiveness of Guselkumab in Psoriasis: A Multicenter Retrospective Study
2025-04-010
OAAI